Healthtech platform Semble raises £30m led by Revaia with Partech
This article covers Semble, a healthtech startup, which has raised £30m in a series C funding round to accelerate the rollout of its care orchestration platform across the UK and Europe. The funding will support expansion into large private healthcare groups, growth of its integrations ecosystem and development of an AI orchestration layer for outpatient care, targeting private outpatient providers and parts of the UK and European healthcare system.
Semble, a healthtech startup, has raised £30m in a series C funding round to accelerate the rollout of its care orchestration platform across the UK and Europe. The funding will be used to push deeper into large private healthcare groups, expand a growing integrations ecosystem and advance the company’s ambition to act as an AI orchestration layer for outpatient care.
Why it matters
Healthcare providers across the UK and Europe are wrestling with fragmented systems, rising patient demand and changing payment models that increase pressure on operations. Semble’s platform aims to stitch together administrative, clinical and billing workflows for outpatient services, a function that can reduce duplication and handoffs that slow care and raise costs.
The round is notable because it targets the private outpatient market, where many providers still run multiple point solutions. If Semble succeeds in consolidating those workflows, it could change how providers manage capacity, patient experience and billing — areas that matter to both NHS-adjacent services and private operators.
Inside the product
Semble bills itself as a clinical platform for outpatient providers that connects and orchestrates the patient journey across diagnostics, scheduling, billing and other operational systems. The company reports that more than 10 million patients — roughly one in six people in the UK — have received care from clinicians using the platform. It says it works with around 1,700 healthcare businesses across 80 specialities and is used daily by some 16,000 professionals.
The platform is open and built to integrate: Semble now connects with over 1,200 external tools, spanning diagnostics, labs, CRM and billing systems. That breadth of integrations is central to its pitch that it can replace a patchwork of point solutions with a single operational layer.
Named by TIME as one of the World’s Top HealthTech Companies for 2025, Semble counts private hospital groups and clinic chains among its customers. Examples include Nuffield Health, a large UK private healthcare provider; London Doctors Clinic, a network of urgent care clinics; and other groups such as Welbeck, Midland Health, Modality and ProblemShared — a mix that demonstrates adoption across enterprise and outpatient clinic settings.
Who are the investors?
The series C was led by European growth investor Revaia, with participation from Partech as a new backer, and continued support from existing investors Mercia Ventures and Octopus Ventures.
In the announcement, Morgan Kessous, Partner at Revaia, which leads the Series C round, said:
Semble is building the system of action for modern healthcare - a platform with genuine clinical depth, real scale and the trust of healthcare providers across the UK and France. The European healthcare market is being reshaped - by technology, by demand and by shifting patient expectations - and Semble is exceptionally well positioned to lead it. Revaia is proud to back the company with the investment further strengthening its conviction in the long-term transformation of healthcare.
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Founder perspective
In the announcement, Christoph Lippuner, CEO and co-founder of Semble, said:
For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients.
In the announcement, Christoph Lippuner, CEO and co-founder of Semble, added:
What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe.
Since December 2024 the company says it has increased headcount by more than 50 per cent, signalling a rapid hiring phase to support product development and market expansion.
The bigger picture
Semble’s raise feeds into a broader trend: investors and providers are looking for platform-level solutions that reduce operational fragmentation in healthcare. For private outpatient providers — and for parts of the NHS that interface with private partners — the promise is fewer manual handoffs and smoother patient journeys.
Regulatory acceptance and localisation will be key as Semble pushes into France and other European markets; the company highlights progress in France as an indicator of "regulatory maturity." The move also reflects ongoing investor appetite for healthtech companies that combine clinical workflows with data and AI capabilities.
The deal underscores continued momentum in European healthtech funding for companies aiming to simplify healthcare operations and suggests further consolidation as providers seek interoperable infrastructure that can scale across borders.
They've invested in Semble
Get to know these healthtech investors
| Investors | Investment Focus | Startup Investments | Round Size | Connect |
|---|---|---|---|---|
 Revaia( ) | ||||
 Partech( ) | ||||
 Mercia( ) | ||||
| All investors | All investor sectors | All funded startups | All funding rounds |
Click here for a full list of 7,589+ startup investors in the UK